[First-line chemotherapy in advanced ovarian cancer]

Tumori. 1999 May-Jun;85(3 Suppl 1):S23-6.
[Article in Italian]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibiotics, Antineoplastic / therapeutic use
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Carcinoma / drug therapy*
  • Carcinoma / epidemiology
  • Cisplatin / therapeutic use
  • Clinical Trials as Topic
  • Female
  • Humans
  • Italy / epidemiology
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / epidemiology
  • Paclitaxel / therapeutic use
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents
  • Antineoplastic Agents, Alkylating
  • Antineoplastic Agents, Phytogenic
  • Paclitaxel
  • Cisplatin